1. Klein-Weigel, PF, Elitok, S, Ruttloff, A, et al. Superior vena cava syndrome. Vasa. 2020;49(6):437-448. doi: 10.1024/0301-1526/a000908.
Google Scholar | Crossref | Medline2. Talapatra, K, Panda, S, Goyle, S, Bhadra, K, Mistry, R. Superior vena cava syndrome: A radiation oncologist’s perspective. J Cancer Res Therapeut 2016;12(2):515-519. doi:10.4103/0973-1482.177503.
Google Scholar | Crossref | Medline3. Papanikolaou, J, Koukoubani, T, Zakynthinos, E. Superior vena cava cancerous thrombus due to squamous cell tongue cancer: Virchow's triad at its worst version. Thromb Haemostasis. 2019;119(4):512-514. doi: 10.1055/s-0039-1677712.
Google Scholar | Crossref | Medline4. Charbonniez, P, Tager, A, Kwei, L, Gustafson, M. The social media diagnosis of superior vena cava syndrome: A case report. Am J Emerg Med 2019;37(2):370-371. doi:10.1016/j.ajem.2018.06.063.
Google Scholar | Crossref | Medline5. Cho, Y, Gwon, DI, Ko, GY, et al. Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective? Korean J Radiol. 2014;15(1):87-94. doi: 10.3348/kjr.2014.15.1.87.
Google Scholar | Crossref | Medline6. Niu, S, Xu, YS, Cheng, L, Cao, C. Stent insertion for malignant superior vena cava syndrome: effectiveness and long-term outcome. Radiol Med 2017;122(8):633-638. doi:10.1007/s11547-017-0767-1.
Google Scholar | Crossref | Medline7. Gwon, DI, Ko, GY, Kim, JH, Shin, JH, Yoon, HK, Sung, KB. Malignant superior vena cava syndrome: a comparative cohort study of treatment with covered stents versus uncovered stents. Radiology 2013;266(3):979-987. doi:10.1148/radiol.12120517.
Google Scholar | Crossref | Medline | ISI8. Wang, ZS, Li, CW, Li, JX, Wu, WJ, Li, Y, Shi, JG. Covered versus uncovered stent insertion for malignant superior vena cava obstruction. Minim Invasive Ther Allied Technol 2020;29(6):353-358. doi:10.1080/13645706.2019.1653925.
Google Scholar | Crossref | Medline9. Jiao, D, Wu, G, Ren, J, Han, X. Study of self-expandable metallic stent placement intraluminal 125I seed strands brachytherapy of malignant biliary obstruction. Surg Endosc 2017;31(12):4996-5005. doi:10.1007/s00464-017-5481-5.
Google Scholar | Crossref | Medline10. Wu, B, Yin, G, He, X, et al. Endovascular treatment of cancer-associated venous obstruction: Comparison of efficacy between stent alone and stent combined with linear radioactive seeds strand. Vasc Endovasc Surg. 2020;54(7):565-572. doi: 10.1177/1538574420939747.
Google Scholar | SAGE Journals11. Yuan, D, Gao, Z, Zhao, J, Zhang, H, Wang, J. 125I seed implantation for hepatocellular carcinoma with portal vein tumor thrombus: A systematic review and meta-analysis. Brachytherapy 2019;18(4):521-529. doi:10.1016/j.brachy.2019.01.014.
Google Scholar | Crossref | Medline12. Deng, X, Wu, H, Gao, F, et al. Brachytherapy in the treatment of breast cancer. Int J Clin Oncol. 2017;22(4):641-650. doi: 10.1007/s10147-017-1155-5.
Google Scholar | Crossref | Medline13. Tanderup, K, Ménard, C, Polgar, C, Lindegaard, JC, Kirisits, C, Pötter, R. Advancements in brachytherapy. Adv Drug Deliv Rev 2017;109:15-25. doi:10.1016/j.addr.2016.09.002.
Google Scholar | Crossref | Medline14. Yao, LH, Su, L, Liu, L, Sun, HT, Wang, JJ. Stenting of the portal vein combined with different numbers of iodine-125 seed strands: dosimetric analyses. Chin Med J (Engl) 2017;130(18):2183-2189. doi:10.4103/0366-6999.213974.
Google Scholar | Crossref | Medline